SOLTA MEDICAL INC 4
4 · SOLTA MEDICAL INC · Filed Jan 27, 2014
Insider Transaction Report
Form 4
Parr Lisa D
VP,Regulatory/Clinical Affairs
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2014-01-23$0.15/sh−100,000$15,000→ 0 totalExercise: $2.77Exp: 2022-12-11→ Common Stock (100,000 underlying) - Disposition to Issuer
Common Stock
2014-01-23$2.92/sh−3,524$10,290→ 0 total
Footnotes (2)
- [F1]Disposed of pursuant to the merger of the Issuer with Valeant Pharmaceuticals International, a Delaware corporation (the "Merger"), at the merger consideration of $2.92 per share (the "Merger Consideration").
- [F2]This option, which had become fully vested and exercisable, was cancelled at the closing of the Merger in exchange for a cash payment equal to the product of (a) the number of shares underlying this option and (b) the difference between the Merger Consideration and the exercise price per share of this option.